Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim PharmafiledCriticalBoehringer Ingelheim Pharma
Priority to UY26347ApriorityCriticalpatent/UY26347A1/en
Publication of UY26347A1publicationCriticalpatent/UY26347A1/en
La invención se refiere a derivados de bencimidazol sustituidos con arilsulfonamida de la fórmula general (I) en donde los radicales R1, R2, R3 y R4 pueden tener los significados mencionados en las reivindicaciones y en la memoria descriptiva, a un procedimiento para su preparación así como al empleo de derivados de bencimidazol sustituidos con arilsulfonamida como medicamentos, en particular como medicamentos con efecto inhibidor de triptasa.The invention relates to arylsulfonamide substituted benzimidazole derivatives of the general formula (I) wherein the radicals R1, R2, R3 and R4 can have the meanings mentioned in the claims and in the specification, to a process for their preparation as well as well as the use of aryl sulfonamide substituted benzimidazole derivatives as drugs, in particular as drugs with tryptase inhibitory effect.
UY26347A2000-09-202000-09-20
DERIVATIVES OF BENCIMIDAZOLE SUBSTITUTED WITH ARILSULFONAMIDE, PROCEDURE FOR ITS PREPARATION AND ITS USE AS MEDICINES.
UY26347A1
(en)
8,8a-dihydroindeno [1,2-d] thiazole derivatives having a sulfonamido or sulfone substituent at the 2-position, their preparation and their use as pharmaceuticals